Cytek Biosciences
Yahoo Finance • 5 days ago
Cytek Biosciences GAAP EPS of -$0.09 in-line, revenue of $48.1M misses by $0.51M
* Cytek Biosciences press release [https://seekingalpha.com/pr/20608750-cytek-biosciences-reports-second-quarter-2026-financial-results] (CTKB [https://seekingalpha.com/symbol/CTKB]): Q2 GAAP EPS of -$0.09 in-line. * Revenue of $48.1M... Full story
Yahoo Finance • 19 days ago
Cytek Biosciences to Report Second Quarter 2026 Financial Results on August 5, 2026
FREMONT, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced that it will report financial results for the second quarter of 2026 after market close on Wednes... Full story
Yahoo Finance • 26 days ago
Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement
FREMONT, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the opening of a new innovation center in Bellevue, Washington, marking the relocation of its previo... Full story
Yahoo Finance • 2 months ago
Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
NEW YORK, June 5, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, June 22, 2026, to coincide with the... Full story
Yahoo Finance • 5 months ago
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact
FREMONT, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- One year after opening its 8,500-square-foot Singapore facility, spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) is marking a major milestone in its Asia-Pacific (... Full story
Yahoo Finance • 5 months ago
Cytek Biosciences GAAP EPS of -$0.34 misses by $0.30, revenue of $62.1M beats by $3.3M
* Cytek Biosciences press release [https://seekingalpha.com/pr/20416626-cytek-biosciences-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides] (CTKB [https://seekingalpha.com/symbol/CTKB]): Q4 GAAP EPS of -$0.34 miss... Full story
Yahoo Finance • 8 months ago
Aldeyra Therapeutics And 2 Other Promising Penny Stocks For Your Watchlist
As of December 19, 2025, major stock indexes in the United States have shown a notable upswing, with the tech-heavy Nasdaq and benchmark S&P 500 posting weekly gains amid a continued rally in technology shares. This positive momentum in br... Full story
Yahoo Finance • 9 months ago
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
FREMONT, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced its inclusion on TIME’s 2026 list of America’s Growth Leaders. Presented in partnership with global... Full story
Yahoo Finance • 9 months ago
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) announced today that its Cytek® Muse® Micro cell analyzer has been named Drug Discovery Solution of the Year in the 2025 BioTech Breakthrough Award... Full story
Yahoo Finance • 9 months ago
Cytek Biosciences to Participate in Upcoming Investor Conferences
FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences. UBS Global He... Full story
Yahoo Finance • 9 months ago
Cytek reaffirms $196M–$205M 2025 revenue outlook as recurring businesses accelerate
Earnings Call Insights: Cytek Biosciences (CTKB) Q3 2025 MANAGEMENT VIEW * CEO Wenbin Jiang highlighted that "total revenue reached $52.3 million, representing a year-over-year increase of 2% compared to the same period in 2024." Jiang... Full story
Yahoo Finance • 9 months ago
Cytek (CTKB) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool. Date Wednesday, November 5, 2025 at 4:30 p.m. ET Call participants Chief Executive Officer — Wenbin Jiang Chief Financial Officer — William D. McCombe Investor Relations — Paul Goodson Need a quote fro... Full story
Yahoo Finance • 9 months ago
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
FREMONT, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, Cytek Biosciences, Inc. (Nasdaq: CTKB) is taking steps to ens... Full story
Yahoo Finance • 10 months ago
Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025
FREMONT, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the third quarter 2025 after market close on Wednesday, Nove... Full story
Yahoo Finance • 10 months ago
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
FREMONT, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- In a move that strengthens its European operations and enhances service for its customers, spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the reloc... Full story
Yahoo Finance • 11 months ago
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
FREMONT, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- With cancer research and diagnostics driving the need for deeper, faster cellular insights, spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) will showcase its advan... Full story
Yahoo Finance • 11 months ago
3 Promising Penny Stocks With Market Caps Under $600M
As the U.S. stock market reaches new heights, with major indices like the S&P 500 and Dow Jones Industrial Average closing at record levels, investors are keenly eyeing opportunities that may not be immediately obvious. Penny stocks, a ter... Full story
Yahoo Finance • last year
Piper Sandler sees opportunity in dislocated Life Science stocks
Investing.com - Piper Sandler has identified potential buying opportunities in dislocated Life Science Tools & Labs stocks, particularly highlighting Neogenomics (NASDAQ:NEO), Myriad Genetics (NASDAQ:MYGN), and Cytek Biosciences (NASDA... Full story
Yahoo Finance • last year
Cytek Biosciences, Inc. (CTKB): A Bull Case Theory
This stock is one of several featured in our latest research. For more small-cap opportunities with asymmetric return potential, read our free article: 10 Promising SmallCap Stocks Under $1 Billion Market Cap. We came across a bullish the... Full story
Yahoo Finance • last year
Cytek Biosciences to Report Second Quarter 2025 Financial Results on August 6, 2025
FREMONT, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the second quarter 2025 after market close on Wednesday, Aug... Full story